Gland Pharma Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Gland Pharma Receives Tentative Approval for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC)".
Press Release Mar 04 2026
Earlier from Gland Pharma
- Press Release Feb 06 2026
- Press Release Jan 28 2026
- Press Release Jan 07 2026
- Press Release Nov 03 2025